lynestrenol has been researched along with medroxyprogesterone acetate in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (62.50) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
Autio, S; Härkönen, T; Huovinen, K; Lommi, L; Tikkanen, MJ; Varonen, S; Wilska, ML | 1 |
Misdorp, W | 1 |
Kitawaki, J; Okada, H; Yamamoto, T | 1 |
Cremer, P; Kuhn, W; Seidel, D; Teichmann, AT; Wieland, H | 1 |
Arntzenius, AC; Havekes, L; Hessel, LW; Stegerhoek, CI; van Gent, CM | 1 |
Graff-Iversen, S; Tonstad, S | 1 |
Bonte, J; Ide, P; Wijnants, P | 1 |
Pelissier-langbort, C | 1 |
Kistner, RW | 1 |
Prous, JR; Sussmann, AR | 1 |
Fekete, G | 1 |
Rozenbaum, H | 1 |
Akgul, MA; Bozkurt, U; Haberal, A; Kayikcioglu, F; Ozdegirmenci, O | 1 |
Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
2 review(s) available for lynestrenol and medroxyprogesterone acetate
Article | Year |
---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
2 trial(s) available for lynestrenol and medroxyprogesterone acetate
Article | Year |
---|---|
Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
Topics: Adult; Amenorrhea; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Humans; Intellectual Disability; Lipids; Lipoproteins; Lynestrenol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Triglycerides | 1991 |
Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Lynestrenol; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progestins; Prospective Studies; Treatment Outcome | 2011 |
12 other study(ies) available for lynestrenol and medroxyprogesterone acetate
Article | Year |
---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Progestagens and mammary tumours in dogs and cats.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Lynestrenol; Mammary Neoplasms, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins | 1991 |
Induction of estradiol dehydrogenase activity in human uterine endometrium by synthetic steroids.
Topics: 17-Hydroxysteroid Dehydrogenases; Chlormadinone Acetate; Danazol; Endometrium; Enzyme Induction; Estradiol Dehydrogenases; Female; Gestrinone; Humans; In Vitro Techniques; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Steroids | 1988 |
Lipid metabolic changes during hormonal treatment of endometriosis.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Female; Humans; Lipid Metabolism; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pelvic Neoplasms; Pregnadienes; Time Factors; Triglycerides | 1988 |
High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives-differences between two frequently used low-estrogen pills.
Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Smoking | 1981 |
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Delayed-Action Preparations; Female; Health Surveys; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins; Lynestrenol; Medroxyprogesterone Acetate; Norethindrone; Norway; Progestins; Risk Factors; Triglycerides | 2002 |
[Cytologic observations of cervicovaginal smears during hormonal contraception].
Topics: Age Factors; Belgium; Biology; Birth Rate; Cells; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developed Countries; Disease; Europe; Family Planning Services; Fertility; Genitalia; Genitalia, Female; Lynestrenol; Medroxyprogesterone Acetate; Mestranol; Neoplasms; Parity; Physiology; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research; Urogenital System; Uterine Cervical Neoplasms; Uterus; Vagina; Vaginitis | 1972 |
[Contraception using normal dose progestins].
Topics: Androgens; Biology; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Corpus Luteum Hormones; Endocrine System; Ethynodiol Diacetate; Family Planning Services; Hormones; Lynestrenol; Medroxyprogesterone Acetate; Physiology; Progesterone; Testosterone | 1984 |
Newer synthetic progestins for the treatment of endometriosis.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases | 1970 |
[Gas chromatography of oral progestagens and estrogens].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Dimethisterone; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Norethindrone; Norgestrel | 1968 |
Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norethynodrel | 1968 |
[What happens in our patients' bodies to the steroid hormones we prescribe? 2. Synthetic progestins].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norgestrel | 1981 |